This is a sensitive method, suitable for measuring subnanogram amounts of cholesterol. Cholesterol and the intemal standard, epicoprostanol (5-beta-cholestan-3-alpha-oI), are derivatized with pentafluorobenzoyl chloride and detected by electron-capture gas chromatography. The pentafluorobenzoyl esters of cholesterol and the internal standard are easily formed and possess excellent chromatographic and electron-capturing properties. The lower limit of detection of the method, -100 pg injected, is about 500-fold as sensitive as chromatographic methods involving flame-ionization detection. Within-day and between-day coefficients of variation were 4.2% and 8.2%, respectively, for determinations of a urinary cholesterol concentration of 570 p/L (1.47 ,.mot/L). Such sensitivity permits analysis for cholesterol in (e.g.) physiological fluids, tissue samples, and cell cultures that contain very low concentrations of cholesterol.
During the past five years, cholesterol has become widely recognized as a major risk factor for coronary heart disease, and numerous screening programs have been set up to identify individuals with increased cholesterol concentrations (1) . Methods used for such analyses are relatively simple and are based on conventional colorimetric or enzymatic reactions (2, 3) . However, these methods lack sensitivity, and cannot be used in the analysis for cholesterol in physiological fluids other than serum or plasma, nor can they detect the trace amounts of cholesterol present in various serum fractions, tissue samples, or cell cultures. Several gas-chromatographic methods (4-9) have been developed for measurement of cholesterol, but they also lack sufficient sensitivity in the nanogram and subnanogram range.
Here we describe a new electron-capture gas-chromatographic procedure for measuring cholesterol in the nanogram and subnanogram range. The method is based on derivatization of cholesterol with pentafluorobenzoyl chloride and analysis by electron-capture gas chromatography. In this study, we have evaluated both pentafluorobenzoyl chloride and trifluoroacetic anhydride as derivatizing reagents. In addition, we compare the lower limits of detection achievable with the electron-capture detector and those obtained with a flame-ionization detector. We also demonstrate the use of this method in the analysis for cholesterol in physiological fluids such as urine and saliva. 
Materials and Methods

Reagents
Specimen
Saliva and urine were sampled from human volunteers after a 12-h fast. The salivary fluid samples were collected between 0700 and 0800 hours to minimize the effects of diurnal variability. Before collecting the salivary fluid, the subjects rinsed their mouth several times with water, then collected about 10 mL of saliva into 16 x 90 mm plastic tubes. The samples were mixed briefly by inversion, then centrifuged (3500 x g, 20 miii) to remove mucous material. For assays of urinary cholesterol, we used untimed urine samples. Before assay, these samples were also centrifuged at 3500 x g for 20 mm to remove cellular material.
Procedure
Extraction of cholesterol. To analyze urine and salivary fluid for cholesterol, we added 2 mL of each sample to separate 25 x 125 mm screw-capped culture tubes along with 2 mL of de-ionized water, 1 mL of the internal standard (epicoprostanol, 3 mg/U in ethanol), and 15 mL of chloroformimethanol (2/1 by vol). The samples were shaken for 10 min and then centrifuged (1500 x g, 5 mm) to separate the organic and aqueous phases. Using a 10-mL volumetric pipette, we transferred about 9 mL of each chloroform (lower) phase to 16 x 125 mm culture tubes, which were then placed in a 65#{176}C heating block and the organic solvent was evaporated in a stream of nitrogen.
Hydrolysis of cholesterol esters. To hydrolyze the cholesterol esters, we added 2 mL of methanolic KOH, 0.5 mol/L, and heated the samples at 65 #{176}C for 1 h. The samples were vortex-mixed before heating and then again after 30 mm of heating. After hydrolysis, we allowed the tubes to cool, then added 2 mL of de-ionized water and 5 mL of hexane. The tubes were shaken for 10 min, then centrifuged at 600 x g for 15s. Using a Pasteur pipette, we transferred about 4 mL of each hexane (top) layer to separate 16 x 125 mm screw-capped tubes. The samples were then either stored at 4#{176}C or were evaporated and the residues derivatized.
Non-esterified cholesterol was determined by assaying extracts that did not undergo hydrolysis. We mixed samples with 2 mL of methanol instead of methanolic KOH, and we omitted the heating step.
Derivatization. prepared in absolute ethanol at concentrations of 300 and 3 mg/U. Cholesterol standards were prepared at concentrations of 100 and 10mg/U. We further diluted the cholesterol stock standard to prepare the working standards used in the standard curve.
Instruments
For the analyses, we used a Model 5890 gas-chromatograph equipped with a asNi electron-capture detector, a flame-ionization detector, a Model 7673A automatic sampler, and a 5 m x 0.53 mm (i. d.) HP-i methylsilicone microbore column (all from Hewlett-Packard, Palo Alto, CA). Injector, column, and detector temperatures were 280, 253, and 280 #{176}C, respectively. The flow rate for the carrier gas (methane/argon, 5/95 by vol) was 6.0 mL/min. The flow rate for the makeup gas was 30-40 mL/min.
For the mass-spectrometric analysis of the pentafluorobenzoyl esters of cholesterol and epicoprostanol, we used a Hewlett-Packard 5980A mass spectrometer, operated in the chemical ionization mode with gaseous methane. The sample was introduced into the mass spectrometer with a solid sampling probe.
Infrared spectra of dried films of cholesterol, epicoprostanol, and their pentafluorobenzoyl esters were obtained with a Model 1760-X infrared Fourier transform spectrometer (Perkin-Elmer, Norwalk, CT). The samples were dissolved in absolute ethanol, applied to NaC1 plates, and the solvent was thoroughly evaporated before the spectra were obtained.
Statistics
The within-day coefficient of variation (CV) was based on the analysis of 10 samples prepared from a pooled specimen of urine, all of the samples being extracted and analyzed during the same day. The between-day CV was based on the analysis of single samples from the same urine pool on 10 separate days. Separate standard curves were prepared for each between-day analysis. We made only single injections of the extracts and standards. The means and standard deviations were calculated to determine the withinday and total (between-day) CVs.
Results
Chromatography.
Figure 1 depicts chromatogranis obtained for the cholesterol and epicoprostanol standards and for cholesterol in urine and salivary fluid. We confirmed the identity of the cholesterol peaks in the urine and saliva samples by analyzing the pentafluorobenzoyl esters on various chromatographic columns, by temperature programming, and by gas chromatography/mass spectrometry. Also, to check for extraneous peaks that might interfere with the analysis for cholesterol, we ran two different blanks: a water blank, which was carried through the entire procedure to simulate a urine or saliva sample, and a urine blank, which was extracted but not derivatized. Neither blank contained peaks that might interfere with the analysis for cholesterol or epicoprostanol ( Figure 1D ). We also determined cholesterol in a few urine samples that had been hydrolyzed directly with methanolic KOH. The within-day CVs were similar to those achieved with the extraction procedure, and the associated chromatograms were excellent.
Detection limit. To compare the lower limits of detection of the electron-capture detector and the flame-ionization detector, defined as the amount of cholesterol that gave a 10% full-scale deflection, we used the same instruments and the same chromatographic columns. At a single voltage of 63 V, the electron-capture detector could reliably detect 100 pg of cholesterol, compared with a 50-ng detection limit for the flame-ionization detector. Also, the electron-capture detector had more stable baselines and fewer extraneous chromatographic peaks than did the flameionization detector.
We also sought to compare the sensitivity of the pentafluorobenzoyl esters with that of the trifluoroacetyl esters but were prevented from doing so by the low yields of the trifluoroacetyl esters (<2%, even with the use of catalysts). Yields of the pentafluorobenzoyl esters of cholesterol and epicoprostanol, by contrast, exceeded 99%. The yields were determined by measuring the decrease in cholesterol during derivatization as well as the increase in ester formation-the former by using a flame-ionization detector and the latter with an electron-capture detector. Moreover, the infrared spectrum of pentafluorobenzoyl-cholesterol showed the appearance of a characteristic aromatic ester absorption band at 1233 cm' and the complete disappearance of the broad oxygen-hydrogen stretching band at 3400 cnf'. In addition chemical ionization/mass spectrometric analysis of the pentafluorobenzoyl derivative of cholesterol, theoretical mass 580.7 Da, showed a parent ion peak at an mJe ratio of 579.9. These data all support the observation that cholesterol was converted to its pentafluorobenzoyl ester in high yield by reaction with pentafluorobenzoyl chloride. Similar results were obtained for epicoprostanol and its pentafluorobenzoyl ester. Reproducibility and linearity. Within-run and total (between-run) CVs were 4.2% and 8.2%, respectively. We used a pooled urine specimen with a cholesterol concentration of 570 j.gfL (1.47 moIJL) for these determinations. Instrumental variation accounted for about 2.0% of the total variation. Periodic checks on the stability of the pentafluorobenzoyl esters of cholesterol and epicoprostanol showed them to be stable over an eight-day period at room temperature. For our analysis of cholesterol in urine and salivary fluid, we prepared standard curves for cholesterol, injected amounts ranging from 500 pg to 5.0 ng. Figure 2 shows an example of a standard curve used in the analysis for cholesterol. Its slope, y-intercept, and correlation coefficient were 0.243, -0.019, and 0.9992, respectively.
Analysis
for cholesterol in urine and salivary fluid. We used the method described here to measure cholesterol in urine from 20 healthy individuals and in saliva from eight. The mean total cholesterol concentration in urine was 1.12 (SD 0.37) mg/L (2.89, SD 0.9 prnolJL). Urinary cholesterol excretion per 24 h averaged 907.2 (SD 405.5) g (2.35, SD  1.05 mol) . The average cholesterol content of salivary fluid was 1.47 (SD 0.9) mgfL (3.8, SD 2.3 mol/L).
Nonesterified cholesterol constituted 50% of the urine total cholesterol and 78% of the salivary fluid total cholesterol.
DiscussIon
The proposed method possesses the sensitivity required The amount of non-esterified cholesterol we found in urine and salivary fluid contrasts sharply with that in serum, of which only about 25% of the total cholesterol is non-esterified (4). The reasons for this difference remain to be determined.
We have demonstrated that the method is well suited for assay of cholesterol in urine and in salivary fluid, even though the clinical significance of urinary and salivary fluid cholesterol has not yet been determined. We expect that the method will find even greater use as a method for measuring cholesterol in various serum fractions, in tissue samples, and in cell cultures. The method is much more sensitive than existing gas-chromatographic methods (4) (5) (6) (7) , and allows analyses of cholesterol in the nanogram and subnanogram range.
